Skip to main content
. 2018 Oct 5;25(4):803–810. doi: 10.1093/ibd/izy304

FIGURE 2.

FIGURE 2.

Summary of ROC performance at week 6 for clinical remission, mucosal healing, and endoscopic remission: total population (A–C) and vedolizumab-treated population (D–F).